Cynthia Timmers to MAP Kinase Kinase 1
This is a "connection" page, showing publications Cynthia Timmers has written about MAP Kinase Kinase 1.
Connection Strength
0.271
-
Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemia. Leuk Lymphoma. 2018 04; 59(4):1008-1011.
Score: 0.143
-
Whole-exome tumor sequencing study in biliary cancer patients with a response to MEK inhibitors. Oncotarget. 2016 Feb 02; 7(5):5306-12.
Score: 0.128